A Prospective Cohort of Patients With Cervical/Intracranial Arteries Stenosis in China
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: No intervention.
- Who it may be relevant to
- Registry conditions: Cervical Artery Stenosis, Intracranial Artery Stenosis. Basic parameters: 40 years — 80 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The aim of this study is to establish a prospective cohort of patients with cervical/intracranial arteries stenosis in China.
Detailed description
A prospective cohort of patients with cervical/intracranial arteries stenosis from various regions of China will be established. This prospective cohort is used to identify the distribution of risk factors in the patients with cervical/intracranial arteries stenosis.
Interventions
- Other No intervention
no intervention
Primary outcome measures
- Incidence of stroke [Time frame: One year]
Secondary outcome measures (2)
- Changes in the stenosis rate of cervical and intracranial arteries [Time frame: One year]
- Incidence of new clinical vascular events [Time frame: One year]
Eligibility criteria
Inclusion criteria
- Age ≥ 40 and ≤ 80 years;
- Ultrasound or imaging examinations indicating cervical artery stenosis and/or intracranial artery stenosis (including mild, moderate, severe stenosis, or occlusion);
- Willing to participate and signing the informed consent form.
Exclusion criteria
- Patients with stroke occurring within the past year;
- Patients with severe systemic diseases, such as respiratory failure, renal failure, gastrointestinal bleeding, coagulation disorders, malignancies, etc.;
- Patients with a life expectancy of less than one year or those who are unable to complete the study for other reasons.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
China · 1 center
- First Hospital of Jilin University — Changchun
Identifiers
NCT: NCT06595342 · ARTERIES